Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence

1Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Thyroid eye disease (TED) is an autoimmune orbital inflammatory disease which ranges from mild to severe. Tissue remodeling, fibrosis and fat proliferation cause changes in the orbital tissues which can affect esthetics and visual function. In its severe form, it is sight threatening, debilitating, and disfiguring and may lead to social stigma, the embarrassment about which has an impact on the quality of life of those affected and the family members. The pathogenesis of TED, which is influenced by genetic, immunological, and environmental factors, is complex and not fully elucidated. However, it remains unknown what factors determine the severity of the disease. Recent research has revealed a number of diagnostic and prognostic biomarkers of this disease. In this overview of TED, we focus on new insights and perspectives regarding biological agents that may provide a basis for new treatment modalities.

Cite

CITATION STYLE

APA

Nivean, P. D., Madhivanan, N., Kumaramanikavel, G., Berendschot, T. T. J. M., Webers, C. A. B., & Paridaens, D. (2024, March 1). Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence. Hormones. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s42000-023-00498-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free